What is Proteon?
Proteon specializes in the development and management of Plone applications, leveraging extensive experience since 2005. With deep expertise in Plone's source code and infrastructure, Proteon addresses complex challenges including multi-client/server setups, content versioning and staging, caching, fail-over solutions, and integration with external databases via Single Sign-On. Their comprehensive knowledge makes them a distinctive provider in the Plone ecosystem, capable of handling a wide array of technical requirements for hosting and development.
How much funding has Proteon raised?
Proteon has raised a total of $122.2M across 4 funding rounds:
Series A
$12M
Series B
$50M
Unspecified
$15.2M
Series D
$45M
Series A (2007): $12M with participation from Devon Park BioVentures, Bessemer Venture Partners, Intersouth Partners, and TVM Capital
Series B (2009): $50M led by Devon Park BioVentures, MPM Bio IV NVS Strategic Fund, Intersouth Partners, TVM Capital, and Bessemer Venture Partners
Unspecified (2011): $15.2M, investors not publicly disclosed
Series D (2014): $45M featuring TVM Capital, Pharmstandard, Devon Park BioVentures, Abingworth, Inbio Ventures, Intersouth Partners, MPM Capital, Deerfield, and Bessemer Venture Partners
Key Investors in Proteon
TVM Capital
TVM Capital Life Science is a transatlantic venture capital firm focused on investing in innovative life science products and companies. They provide capital and expertise to support the development of breakthrough therapies and medical products that aim to transform healthcare. Their unique strategy includes financing early-stage therapeutics and investing in differentiated commercial-stage medtech, diagnostics, and digital health products. With a strong team and a commitment to partnership, they strive to enable portfolio companies to bring new therapies to market.
Bessemer Venture Partners
Bessemer Venture Partners (Bessemer) is a venture capital firm. The firm has offices in San Francisco, Redwood City, New York City, Boston, Israel, and India. It was established in 1911 as Bessemer Securities. It's headquarters is at Menlo Park, California, US.
Deerfield
Deerfield Management is an investment firm focused on advancing healthcare through investment, intelligence, and philanthropy. The firm supports companies across the healthcare ecosystem with flexible funding models and drives innovation using AI, data, and market research. Deerfield also engages in philanthropic efforts through its New York City-based not-for-profit, Cure, which fosters innovative healthcare initiatives. Their collaborative approach connects people, capital, ideas, and technology to build and enhance healthcare solutions.
What's next for Proteon?
The significant enterprise-level funding and strategic investment received by Proteon suggest a phase of accelerated scaling and market expansion. This capital infusion is likely to fuel further development of their Plone application management services, potentially enabling expansion into new markets or enhancement of their technological capabilities. The company's robust history of securing diverse rounds of financing points towards a strategic approach to growth, aiming to solidify its leadership in the specialized Plone market.
See full Proteon company page
